Snyder G L, Fisone G, Morino P, Gundersen V, Ottersen O P, Hökfelt T, Greengard P
Laboratory of Molecular and Cellular Neuroscience, Rockefeller University, New York, NY 10021.
Proc Natl Acad Sci U S A. 1993 Dec 1;90(23):11277-81. doi: 10.1073/pnas.90.23.11277.
Despite physiological evidence that cholecystokinin (CCK) is an excitatory neurotransmitter in the brain, little is known about its mechanism of action. CCK immunoreactivity in the brain, including projections to the striatum, is primarily attributable to the sulfated octapeptide CCK-8S. We report here that CCK-8S abolishes cAMP-dependent phosphorylation of a dopamine- and cAMP-regulated 32-kDa phosphoprotein (DARPP-32) in striatal neurons. The effect of CCK-8S is prevented by antagonists of CCKB and N-methyl-D-aspartate receptors. Our results support a model in which CCK-8S, originating from CCK or CCK/glutamate corticostriatal neurons, promotes the release of an excitatory neurotransmitter that causes the dephosphorylation and inactivation of DARPP-32, a potent protein phosphatase inhibitor, thereby modulating neuronal excitability.
尽管有生理学证据表明胆囊收缩素(CCK)是大脑中的一种兴奋性神经递质,但其作用机制却鲜为人知。大脑中的CCK免疫反应性,包括向纹状体的投射,主要归因于硫酸化八肽CCK-8S。我们在此报告,CCK-8S可消除纹状体神经元中多巴胺和cAMP调节的32 kDa磷蛋白(DARPP-32)的cAMP依赖性磷酸化。CCKB和N-甲基-D-天冬氨酸受体拮抗剂可阻止CCK-8S的作用。我们的结果支持这样一个模型,即源自CCK或CCK/谷氨酸皮质纹状体神经元的CCK-8S促进一种兴奋性神经递质的释放,该神经递质导致强效蛋白磷酸酶抑制剂DARPP-32的去磷酸化和失活,从而调节神经元兴奋性。